Tretinoin (ATRA) + Retifanlimab
NCT05345002
University of Pennsylvania (Stephen Bagley) · Phase 2 · Recruiting · Enrollment 55
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.
Disease Pipeline Tools IDH-mutant glioma
IDH-mutant glioma
Programs, trials, and reported response and survival for IDH-mutant glioma.
Tretinoin (ATRA) + Retifanlimab
University of Pennsylvania (Stephen Bagley) · Phase 2 · Recruiting · Enrollment 55
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.